Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs) EQUITY
$102.06
pos +0.15
+0.15%
Today's Range: 100.55 - 103.24 | GILD Avg Daily Volume: 10,944,600
Last Update: 09/04/15 - 4:00 PM EDT
Volume: 10,285,419
YTD Performance: 8.12%
Open: $101.03
Previous Close: $101.91
52 Week Range: $85.95 - $123.37
Oustanding Shares: 1,467,605,502
Market Cap: 153,027,225,694
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 11 11 11
Moderate Buy 3 3 3 3
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.47 1.47 1.47 1.47
Latest Dividend: 0.43
Latest Dividend Yield: 1.65%
Dividend Ex-Date: 09/14/15
Price Earnings Ratio: 10.96
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
10.96 11.00 24.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-11.11% -6.87% 253.30%
GROWTH 12 Mo 3 Yr CAGR
Revenue 122.20 1.97 0.43
Net Income 294.40 3.32 0.62
EPS 305.00 3.39 0.63
Earnings for GILD:
EBITDA 16.32B
Revenue 24.89B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $3.03 $2.98 $11.99 $10.53
Number of Analysts 1 1 1 1
High Estimate $3.03 $2.98 $11.99 $10.53
Low Estimate $3.03 $2.98 $11.99 $10.53
Prior Year $1.79 $2.38 $7.91 $11.99
Growth Rate (Year over Year) 69.27% 25.21% 51.58% -12.18%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Guest Contributor

 | Sep 3, 2015 | 1:15 PM EDT

Following a 40% decline, now looks good for scaling into the stock.

By

Jim Cramer

 | Aug 31, 2015 | 11:12 AM EDT

Which means interest rate hikes are being built into prices.

By

Chris Versace and Lenore Hawkins

 | Aug 26, 2015 | 2:00 PM EDT

We saw this coming, but there's more to the recent turmoil than China.

By

David Katz

 | Aug 24, 2015 | 11:00 AM EDT

Although itis never comfortable buying into a selloff, it will look very smart in 6 months.

By

Bret Jensen

 | Aug 24, 2015 | 9:00 AM EDT

It could be time to deploy some of your dry powder.

By

Bret Jensen

 | Aug 18, 2015 | 1:00 PM EDT

Bet on small-caps with big-name collaborators.

By

James "Rev Shark" DePorre

 | Aug 14, 2015 | 4:26 PM EDT

Still, momentum is cooling and valuation is an issue in more cases.

By

David Katz

 | Jul 30, 2015 | 11:00 AM EDT

Drugmaker has one of the best showings of earnings season.

By

David Katz

 | Jul 30, 2015 | 8:30 AM EDT

Drugmaker has one of the best showings of earnings season.

By

Bret Jensen

 | Jul 29, 2015 | 1:16 PM EDT
Markets still are holding their gains as we come to midday. Interestingly, the biotech index is off today despite great results and a solid up day from Gilead Sciences (GILD), one of the four horsemen of biotech. Some infrastructure plays such as Mastec (MTZ) and Terex (TEX) are having nice days and are up 3% or so on the day.
A pair of eveningstar patterns have formed on the S&P 500 index chart. The eveningstar...

As I mentioned about a week ago, it appears BGB might trace out of its downtrend.

Micron appears headed for a positive close. The stock is up slightly today and is wor...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.